相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 保存条件:
常温,避光
- 克隆性:
单克隆
- 抗体名:
Coagulation Factor IX / F9抗体
免疫原 :
Recombinant Human Coagulation Factor IX / F9 protein (Catalog#11503-H08H)
Antibody Type : Rabbit Polyclonal Antibody ( Antibody Purification Platform )
抗体宿主 :
Rabbit IgG
缓冲液 : 0.2 μm filtered solution in PBS, 5% trehalose may be added in some batches. Please read the hardcopy of COA or contact our customer service to confirm the formulation.
制备方法 :
Produced in rabbits immunized with purified, recombinant Human Coagulation Factor IX / F9 (rh Coagulation Factor IX / F9; Catalog#11503-H08H; AAB59620.1; Met 1-Thr 461). Coagulation Factor IX / F9 specific IgG was purified by Human Coagulation Factor IX / F9 affinity chromatography.
Coagulation Factor IX / F9抗体Background
Coagulation factor IX, also known as Christmas factor, Plasma thromboplastin component and PTC, is a secreted protein which belongs to thepeptidase S1 family. Coagulation factor IX / F9 contains two EGF-like domains, one Gla (gamma-carboxy-glutamate) domain and one peptidase S1 domain. Coagulation factor IX / F9 is a vitamin K-dependent plasma protein that participates in the intrinsic pathway of blood coagulation by converting factor X to its active form in the presence of Ca2+ions, phospholipids, and factor VIIIa. Defects in Coagulation factor IX / F9 are the cause of thrombophilia due to factor IX defect which is a hemostatic disorder characterized by a tendency to thrombosis.Defects in Coagulation factor IX / F9 are also the cause of recessive X-linked hemophilia B (HEMB) which also known as Christmas disease.
Coagulation Factor IX / F9抗体相关产品如下:
hz-2271R HCMV/Cytomegalovirus Glycoprotein B人巨细胞病毒抗体
hz-3211R Phospho-HDAC4 (Ser632) + HDAC5 (Ser498) + HDAC7 (Ser486)磷酸化组蛋白去乙酰化酶4/5/7抗体
hz-2896R Phospho-HER2 (Tyr877)磷酸化HER2受体抗体
hz-3358R Phospho-HSL (Ser660)磷酸化荷尔蒙敏感脂肪酶抗体
hz-5728R HURP肝癌上调蛋白抗体
hz-2145R Hrasls3HRAS样抑制因子3抗体
hz-4193R CBS丝氨酸羧甲半胱氨酸合成酶抗体
hz-5727R HEC1癌细胞高表达蛋白Hec1抗体
hz-3224R Phospho-HSL (Ser865)磷酸化荷尔蒙敏感脂肪酶抗体
hz-2895R HDAC1组蛋白去乙酰化酶1抗体
hz-13801R C1GALT1C1半乳糖基转移酶2抗体
hz-0928R phospho-HP1 alpha (Tyr24)磷酸化异染色质蛋白1抗体(果蝇)
hz-0930R Phospho-HP1(Tyr43)异染色质蛋白1磷酸化抗体(果蝇)
hz-1447R HIF 2 alpha缺氧诱导因子2α /HIF-2α抗体
hz-1430R H1N1 matrix protein 2甲型流感病毒M2抗体
hz-1538R HSP47热休克蛋白-47抗体
hz-0990R HPV16 E6 protein人类乳头状瘤病毒16抗体
hz-0737R HIF-1 Alpha缺氧诱导因子1α 抗体HIF-1α
hz-0349R Histone H3组蛋白H3抗体
hz-0869R HHV8 ORF K2人类疱疹病毒8抗体/疱疹病毒8型
hz-0866R HHV4/CMV人类巨细胞病毒抗体
hz-0746R HHV8 ORF50人类疱疹病毒8抗体
hz-1690R H2N2 Hemagglutinin甲型流感病毒血凝素抗体(H2N2)
hz-0808R HCMV UL49人巨细胞病毒UL49蛋白抗体
hz-1279R HLA E人类白细胞抗原E抗体
hz-15448R HECTD3E3连接酶抑制素受体3抗体
hz-6447R HSP1精子鱼精蛋白P1抗体
hz-1025R HGF肝细胞生长因子抗体
hz-1813R HDAC2组蛋白去乙酰化酶2抗体
hz-0343R large S protein人乙肝病毒Large S蛋白抗体
hz-1085R ErbB 4HER4抗体
hz-0402R BRI3BP宫颈癌原基因1/bri3结合蛋白抗体
hz-0221R HCV Core protein丙肝病毒核心抗原C区抗体
hz-0218R HCV-NS1丙型肝炎病毒-NS1抗体
hz-0219R HCV-NS3丙型肝炎病毒-NS3抗体
hz-0213R HCV-NS4a丙型肝炎病毒-NS4a抗体
hz-0344R H5N1 Matrix Protein 2A型禽流感病毒H5N1-M2蛋白抗体
hz-1235R Hyaluronidase-1透明质酸酶/玻璃酸酶抗体
hz-0540R HAI-1肝细胞生长因子激活物抑制剂抗体
hzm-0966M HA tag(12CA5)HA tag标签单克隆抗体
hz-0408R Heamachrome血红素抗体
hz-0212R Hepatitis E Virus ORF3 戊型肝炎病毒抗体
hz-1814R HRG1神经调节蛋白1抗体
hz-1817R HRG Beta1神经胶质生长因子/神经调节蛋白β抗体
hz-1818R HINT1组氨酸三聚体核苷结合蛋白1抗体
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验Ex Vivo Stromal Cell Electroporation of Factor IX cDNA for Treatment of Hemophilia B
Hemophilia B is an X-linked genetic disorder that typically results from chronic circulating deficiency of blood coagulation factor IX (FIX) (1). While the occurrence of hemophilia B is significantly less frequent than hemophilia A (factor
Studies on Coagulation Incompatibilities for Xenotransplantation
) circulating PC in the presence of thrombin. Tissue factor pathway inhibitor (TFPI), is the primary inhibitor of tissue factor (TF)-induced coagulation. TFPI directly inhibits the activated factor X (FXa) and blocks the procoagulant activity of the TF/factor
Identification of Mutations in the Human Factor VII Gene
by activating both arms of the coagulation cascade via its action upon factors IX and X (5 ).
技术资料暂无技术资料 索取技术资料




